Skip to content

    Children's Health

    Font Size
    A
    A
    A

    Waning Whooping Cough Immunity Blamed in Outbreaks

    Teens have very little protection just a few years after vaccination, study finds

    WebMD News from HealthDay

    By Amy Norton

    HealthDay Reporter

    FRIDAY, Feb. 5, 2016 (HealthDay News) -- The booster shot given to pre-teens to ward off whooping cough only works for a short time -- a fact that has played a big role in recent outbreaks in California, a new study finds.

    The study, of children in one large California health plan, found that the whooping cough booster shot offered "moderate" protection for about a year. But that immunity waned so quickly that little protection remained after two or three years.

    Experts said the findings, reported online Feb. 5 and in the March print issue of Pediatrics, underscore the limits of today's whooping cough vaccines.

    It's been clear for years that cases of whooping cough, or pertussis, are rising in the United States. In 2012, more than 48,000 cases were reported nationwide -- the highest number since 1955, according to the U.S. Centers for Disease Control and Prevention.

    What's more, the agency says, older children and teenagers are accounting for a growing proportion of cases.

    A major reason, experts believe, is that in the 1990s, U.S. health officials switched from the traditional whooping cough vaccine to a new one known as DTaP -- which also protects against diphtheria and tetanus. DTaP works well in the short term, the CDC says, but slowly wanes each year after a child's final dose, which is given around age 5.

    So a booster shot, called Tdap, is routinely given to kids at age 11 or 12. But that shot doesn't last long either.

    "The issue is, the old vaccine against whooping cough had a difficult safety profile," explained Dr. Paul Offit, director of the Vaccine Education Center and a professor of infectious diseases at Children's Hospital of Philadelphia.

    It could cause high fevers and seizures in young children, he said -- which understandably worried parents. There were also concerns about possible, albeit rare, neurological effects, Offit added.

    That led to the development of DTaP, which has far fewer antigens than the old vaccine, Offit said. Antigens are proteins that trigger an immune system response; with fewer antigens, DTaP is much less likely to cause side effects. But it also offers shorter-lived immunity.

    1 | 2 | 3

    Today on WebMD

    child with red rash on cheeks
    What’s that rash?
    plate of fruit and veggies
    How healthy is your child’s diet?
     
    smiling baby
    Treating diarrhea, fever and more.
    Middle school band practice
    Understanding your child’s changing body.
     

    worried kid
    fitArticle
    jennifer aniston
    Slideshow
     
    Measles virus
    Article
    sick child
    Slideshow
     

    babyapp
    New
    Child with adhd
    Slideshow
     
    rl with friends
    fitSlideshow
    Child Coughing or Sneezing into Elbow
    Article